Anti-CD20 antibodies and methods of use

Details for Australian Patent Application No. 2007324130 (hide)

Owner Vaccinex, Inc.

Inventors Fisher Jr., Terrence L.; Smith, Ernest S.

Agent Fisher Adams Kelly

Pub. Number AU-B-2007324130

PCT Pub. Number WO2008/063771

Priority 60/850,604 10.10.06 US; 11/869,170 09.10.07 US

Filing date 10 October 2007

Wipo publication date 29 May 2008

Acceptance publication date 20 September 2012

International Classifications

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/0781 Undifferentiated human, animal or plant cells, e.g. cell lines - B cells

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/063771 Priority application(s): WO2008/063771

20 September 2012 Application Accepted

  Published as AU-B-2007324130

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007324135-Antibodies to lymphotoxin-alpha

2007324129-Reducing optical interference in a fluidic device